Businesses turn to Sheppard to deliver sophisticated counsel to help clients move ahead. With more than 1,200 lawyers located in 16 offices worldwide, our client-centered approach is grounded in nearly a century of building enduring relationships on trust and collaboration. Our broad and diversified practices serve global clients—from startups to Fortune 500 companies—at every stage of the business cycle, including high-stakes litigation, complex transactions, sophisticated financings and regulatory issues. With leading edge technologies and innovation behind our team, we pride ourselves on being a strategic partner to our clients.
Jonathan S. Aronie’s articles from Sheppard, Mullin, Richter & Hampton LLP are most popular:
with Inhouse Counsel
in China
with readers working within the Retail & Leisure and Law Firm industries
On August 13, 2018, President Trump signed into law the National
Defense Authorization Act (NDAA) of 2019. While the annual NDAAs
are tracked, analyzed, and picked apart with great care by the
federal contracting community, the health care industry typically
pays them little mind. But ignoring the 2019 NDAA would be a big
mistake, because tucked within its more than 1,000 sections is one
that will have a significant impact on many health care industry
players. It's known as Section 889. Read our thoughts on
Section 889's impact on the Health Care industry here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
